J Korean Med Assoc.
2022 Jan;65(1):37-43. 10.5124/jkma.2022.65.1.37.
Treatment of advanced heart failure
- Affiliations
-
- 1Division of Cardiology, Severance Hospital, Yonsei University School of Medicine, Seoul, Korea
- 2Department of Biochemistry and Molecular Biology, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2525107
- DOI: http://doi.org/10.5124/jkma.2022.65.1.37
Abstract
- Background
The development of medical and device treatment of heart failure (HF) has improved the survival and quality of life in HF patients. However, not all HF patients respond well to these up-to-date HF treatments. We have termed these non-responders as advanced HF patients. The definition, diagnosis, and treatment of advanced HF are discussed in this review article.
Current Concepts
After current guideline-directed treatments, advanced HF patients can experience aggravation and decompensation, usually resulting in hospitalization for the symptoms and volume control. Recurrent decompensation or hospitalization can cause a vicious cycle between the heart and other vital organs, such as the kidney and liver. Current and up-to-date guidelines recommend treatments, including heart transplant, left ventricular assist device (LVAD), and hospice care, for advanced HF. Given the limitation of heart transplant donors, LVAD can be used as a bridge to transplant, in addition to destination therapy. Updated LVAD system can reduce pump-related thrombosis, stroke, and bleeding.
Discussion and Conclusion
Current guidelines suggest early recognition of advanced HF and referral to advanced HF specialists. Despite advances in the treatments of advanced HF, unmet needs for further improving clinical outcomes and quality of life exist.
